Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors
Journal Article
·
· ACS Medicinal Chemistry Letters
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, United States
- Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, United States
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, United States; Department of Biochemistry and Biophysics, Peking University Health Science Center, Beijing 100191, China
- Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States
- Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, United States; Belfer Center for Applied Cancer Science, Boston, Massachusetts 02215, United States
Abstract not provided
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- NIH
- OSTI ID:
- 1576008
- Journal Information:
- ACS Medicinal Chemistry Letters, Journal Name: ACS Medicinal Chemistry Letters Journal Issue: 11 Vol. 10; ISSN 1948-5875
- Publisher:
- American Chemical Society (ACS)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors
Journal Article
·
Wed May 15 00:00:00 EDT 2019
· Cancer Discovery
·
OSTI ID:1569902
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Journal Article
·
Mon Jan 11 23:00:00 EST 2010
· Nature
·
OSTI ID:1006040
Structural Basis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors
Journal Article
·
Thu May 14 00:00:00 EDT 2020
· J. Med. Chem.
·
OSTI ID:1630324